NTI — Neurotech International Cashflow Statement
0.000.00%
- AU$17.84m
- AU$14.81m
- AU$2.58m
Annual cashflow statement for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0 | 0 | 0.06 | 0.158 | 0.137 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.32 | -2.96 | -6.32 | -4.6 | -9.02 |
| Capital Expenditures | — | -0.003 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.003 | 0 | — | — |
| Financing Cash Flow Items | -0.443 | 0 | — | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.13 | 0.026 | 9.45 | 11.2 | 0.43 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.82 | -2.93 | 3.13 | 6.6 | -8.59 |